{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:54:15Z","timestamp":1791053655921,"version":"4.1.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1097\/cji.0b013e318135472c","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T23:02:58Z","timestamp":1236207778000},"page":"715-726","source":"Crossref","is-referenced-by-count":72,"title":["In Vivo Targeting of Antigens to Human Dendritic Cells Through DC-SIGN Elicits Stimulatory Immune Responses and Inhibits Tumor Growth in Grafted Mouse Models"],"prefix":"10.1097","volume":"30","author":[{"given":"Anke","family":"Kretz-Rommel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Dakappagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruurd","family":"Torensma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Faas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine S.","family":"Bowdish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210219","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1084\/jem.194.6.769","article-title":"Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo","volume":"194","author":"Hawiger","year":"2001","journal-title":"J Exp Med"},{"key":"R2-5-20210219","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nri1592","article-title":"Dendritic cells as therapeutic vaccines against cancer","volume":"5","author":"Banchereau","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R3-5-20210219","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1084\/jem.189.2.371","article-title":"Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization","volume":"189","author":"Regnault","year":"1999","journal-title":"J Exp Med"},{"key":"R4-5-20210219","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1084\/jem.20020338","article-title":"Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells","volume":"195","author":"Kalergis","year":"2002","journal-title":"J Exp Med"},{"key":"R5-5-20210219","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1182\/blood-2004-02-0637","article-title":"Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo","volume":"104","author":"Biragyn","year":"2004","journal-title":"Blood"},{"key":"R6-5-20210219","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1084\/jem.20021598","article-title":"Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance","volume":"196","author":"Bonifaz","year":"2002","journal-title":"J Exp Med"},{"key":"R7-5-20210219","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.4049\/jimmunol.172.5.2845","article-title":"Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules","volume":"172","author":"Ramakrishna","year":"2004","journal-title":"J Immunol"},{"key":"R8-5-20210219","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.1158\/0008-5472.CAN-05-0938","article-title":"Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice","volume":"65","author":"Mahnke","year":"2005","journal-title":"Cancer Res"},{"key":"R9-5-20210219","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.4049\/jimmunol.177.4.2276","article-title":"Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1","volume":"177","author":"Carter","year":"2006","journal-title":"J Immunol"},{"key":"R10-5-20210219","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cellimm.2006.05.001","article-title":"Induction of CD8+ T cell responses through targeting of antigen to Dectin-2","volume":"239","author":"Carter","year":"2006","journal-title":"Cell Immunol"},{"key":"R11-5-20210219","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1182\/blood-2005-01-0318","article-title":"Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody","volume":"106","author":"Tacken","year":"2005","journal-title":"Blood"},{"key":"R12-5-20210219","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/intimm\/13.10.1283","article-title":"Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN","volume":"13","author":"Park","year":"2001","journal-title":"Int Immunol"},{"key":"R13-5-20210219","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/intimm\/dxh084","article-title":"Functional comparison of the mouse DC-SIGN, SIGNR1, SIGNR3 and Langerin, C-type lectins","volume":"16","author":"Takahara","year":"2004","journal-title":"Int Immunol"},{"key":"R14-5-20210219","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/intimm\/dxl011","article-title":"Functional comparison of mouse CIRE\/mouse DC-SIGN and human DC-SIGN","volume":"18","author":"Caminschi","year":"2006","journal-title":"Int Immunol"},{"key":"R15-5-20210219","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.1093933","article-title":"Development of a human adaptive immune system in cord blood cell-transplanted mice","volume":"304","author":"Traggiai","year":"2004","journal-title":"Science"},{"key":"R16-5-20210219","first-page":"5214","article-title":"Consistent antibody response against ganglioside GD2 induced in patients with melanoma by a GD2 lactone-keyhole limpet hemocyanin conjugate vaccine plus immunological adjuvant QS-21","volume":"9","author":"Ragupathi","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R17-5-20210219","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.1158\/1078-0432.CCR-04-0482","article-title":"Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin","volume":"10","author":"Krug","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R18-5-20210219","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3816\/CGC.2005.n.020","article-title":"Prostate-specific membrane antigen vaccines: naked DNA and protein approaches","volume":"4","author":"Slovin","year":"2005","journal-title":"Clin Prostate Cancer"},{"key":"R19-5-20210219","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0161-5890(95)00099-2","article-title":"In vitro and in vivo inhibition of complement activity by a single-chain Fv fragment recognizing human C5","volume":"32","author":"Evans","year":"1995","journal-title":"Mol Immunol"},{"key":"R20-5-20210219","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4049\/jimmunol.176.1.426","article-title":"Internalizing antibodies to the C-type lectins, L-SIGN and DC-SIGN, inhibit viral glycoprotein binding and deliver antigen to human dendritic cells for the induction of T cell responses","volume":"176","author":"Dakappagari","year":"2006","journal-title":"J Immunol"},{"key":"R21-5-20210219","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.4049\/jimmunol.164.9.4465","article-title":"The roles of CD28 and CD40 ligand in T cell activation and tolerance","volume":"164","author":"Howland","year":"2000","journal-title":"J Immunol"},{"key":"R22-5-20210219","first-page":"5523","article-title":"Antimetastatic effect of CpG DNA mediated by type I IFN","volume":"61","author":"Hafner","year":"2001","journal-title":"Cancer Res"},{"key":"R23-5-20210219","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1182\/blood-2005-03-1252","article-title":"DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production","volume":"107","author":"Caparros","year":"2006","journal-title":"Blood"},{"key":"R24-5-20210219","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000030438","article-title":"Mature dendritic cells induce T-helper type-1-dominant immune responses in patients with metastatic renal cell carcinoma","volume":"63","author":"Rieser","year":"1999","journal-title":"Urol Int"},{"key":"R25-5-20210219","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.4049\/jimmunol.178.9.5595","article-title":"CD200 expression on tumor cells suppresses anti-tumor immunity: new approaches to cancer immunotherapy","volume":"178","author":"Kretz-Rommel","year":"2007","journal-title":"J Immunol"},{"key":"R26-5-20210219","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0167-5699(95)80046-8","article-title":"The human immune system in hu-PBL-SCID mice","volume":"16","author":"Tary-Lehmann","year":"1995","journal-title":"Immunol Today"},{"key":"R27-5-20210219","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","article-title":"Enhancement of antitumor immunity by CTLA-4 blockade","volume":"271","author":"Leach","year":"1996","journal-title":"Science"},{"key":"R28-5-20210219","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1245\/ASO.2005.03.536","article-title":"Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I\/II study","volume":"12","author":"Maker","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"R29-5-20210219","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/intimm\/10.12.1969","article-title":"Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic\/suppressive state","volume":"10","author":"Takahashi","year":"1998","journal-title":"Int Immunol"},{"key":"R30-5-20210219","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1172\/JCI25947","article-title":"Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells","volume":"115","author":"Dannull","year":"2005","journal-title":"J Clin Invest"},{"key":"R31-5-20210219","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevOncog.v11.i1.10","article-title":"Dendritic cell-based vaccines: from mouse models to clinical cancer immunotherapy","volume":"11","author":"Schreurs","year":"2000","journal-title":"Crit Rev Oncog"},{"key":"R32-5-20210219","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1073\/pnas.0610383104","article-title":"DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes","volume":"104","author":"Bozzacco","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R33-5-20210219","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1358\/dot.2002.38.11.820135","article-title":"The use of carbohydrate antigens for the preparation of vaccines for therapy in breast cancer","volume":"38","author":"Croce","year":"2002","journal-title":"Drugs Today (Barc)"},{"key":"R34-5-20210219","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0264-410X(02)00534-0","article-title":"Dendritic cell KLH loading requirements for efficient CD4+ T-cell priming and help to peptide-specific cytotoxic T-cell response, in view of potential use in cancer vaccines","volume":"21","author":"Millard","year":"2003","journal-title":"Vaccine"},{"key":"R35-5-20210219","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/intimm\/dxl022","article-title":"Expression of human DEC-205 (CD205) multilectin receptor on leukocytes","volume":"18","author":"Kato","year":"2006","journal-title":"Int Immunol"},{"key":"R36-5-20210219","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0161-5890(97)00042-4","article-title":"Humanized porcine VCAM-specific monoclonal antibodies with chimeric IgG2\/G4 constant regions block human leukocyte binding to porcine endothelial cells","volume":"34","author":"Mueller","year":"1997","journal-title":"Mol Immunol"}],"container-title":["Journal of Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CJI.0b013e318135472c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T20:01:36Z","timestamp":1621886496000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002371-200710000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/cji.0b013e318135472c","relation":{},"ISSN":["1524-9557"],"issn-type":[{"value":"1524-9557","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}